Enter assignee name

EPO Patents = 1

Trademarks = 3

Forward Citations = 5

Loading Chart...

5 inventors (with patents filed for the assignee):

Jan Tavernier (11 out of 62 patents)

Nikolai Kley (11 out of 22 patents)

Lennart Zabeau (9 out of 15 patents)

4. Erik Depla (8 out of 8 patents)

5. Anje Cauwels (2 out of 10 patents)

11 patents: Sort by Forward Citations

1. 12448447 - CD8 binding agents (2025-10-21),

2. 12410225 - Modulation of dendritic cell lineages (2025-09-09),

3. 12351633 - PD-1 and PD-L1 binding agents (2025-07-08),

4. 12351614 - CLEC9A-based chimeric protein complexes (2025-07-08),

5. 12091463 - Clec9A binding agents comprising a recombinant heavy-chain only antibody (VHH) (2024-09-17),

6. 12084497 - SIRP1α targeted chimeric proteins and uses thereof (2024-09-10),

7. 11896643 - Fibroblast binding agents and use thereof (2024-02-13),

8. 11566072 - CD8 binding agents (2023-01-31),

9. 11498966 - PD-1 and PD-L1 binding agents (2022-11-15),

10. 11440943 - Therapeutic interferon alpha 1 proteins (2022-09-13),

11. 10906985 - Targeted engineered interferon and uses thereof (2021-02-02),

Orionis Biosciences is a biotechnology company focused on developing innovative therapies for a variety of diseases. With a strong emphasis on research and development, we strive to bring cutting-edge solutions to patients in need. Our team of scientists and experts are dedicated to advancing the field of biosciences and making a positive impact on global health.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

11 Patents

#106 in Waltham, MA

#1,611 in Massachusetts

#26,680 in US

#50,159 in the World

Waltham, MA, United States of America

Orionis Biosciences, Inc.